Fri. 29 Mar 2024, 12:53am ET
Benzinga
Earnings, Earnings Misses, News
Unicycive Therapeutics (NASDAQ:UNCY) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.17) by 105.88 percent. This is a 31.37 percent increase over losses of $(0.51) per share from the same period last year.